In September 2020, ACRO released a White Paper to provide an overview of key issues in the decentralization of clinical trials and to introduce two DCT tools: a Quality-by-Design Manual and a Template for DCT Risk Assessment Considerations.
ACRO members are dedicated to helping bring quality-based principles, risk-assessment tools, and patient-centricity to the decentralized trials process.
Explore some of ACRO’s additional DCT resources: